Stay updated on Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedCore content updated with a new disease term and a new version, plus a critical operating-status notice; an old disease term and prior version were removed.SummaryDifference3%
- Check17 days agoChange DetectedVersion bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedOnly a version bump from v3.0.0 to v3.0.2; no other content changes detected.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to radiation exposure and adrenal cortex carcinoma. Notably, the revision number has been updated to v3.0.0.SummaryDifference2%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.